The Phase IIa study REIMAGINE evaluated the safety and preliminary efficacy of vafidemstat in agitation/aggression in borderline personality disorder (BPD), attention-deficit/hyperactivity disorder ...
Representatives from Line Design Studio will respond to you via e-mail. By sending this message you agree to the T&C.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback